Differential roles of orexin receptor-1 and -2 in the regulation of Non-REM and REM sleep

Michihiro Mieda, Emi Hasegawa, Yaz Y. Kisanuki, Christopher M. Sinton, Masashi Yanagisawa, Takeshi Sakurai

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Orexin-A and orexin-B are hypothalamic neuropeptides that play critical roles in the maintenance of wakefulness. Intracerebroventricular (ICV) administration of orexin-A has been shown to promote wakefulness and suppress both rapid eye movement (REM) sleep and non-REM (NREM) sleep through the orexin receptor-1 (OX1R) and orexin receptor-2 (OX2R). Here, we elucidated the differential roles of orexin receptors in the regulation of sleep and wakefulness by comparing the effects of ICV orexin-A administration in wild-type, OX1R, and OX2R mice. The effects of orexin-A on wakefulness and NREM sleep were significantly attenuated in both knock-out mice as compared with wild-type mice, with substantially larger attenuation in OX2R mice than in OX1R mice. These results suggest that although the OX2R-mediated pathway has a pivotal role in the promotion of wakefulness, OX1R also plays additional roles in promoting arousal. In contrast, suppression of REM sleep by orexin-A administration was slightly and similarly attenuated in both OX1R and OX2R mice, suggesting a comparable contribution of the two receptors to REM sleep suppression. Histological studies demonstrated differential distributions of each receptor subtype in distinct neuronal populations with specific neurotransmitter identities in brainstem cholinergic/monoaminergic neurons. In the laterodorsal tegmental and pedunculopontine tegmental nuclei especially, cholinergic neurons exclusively expressed OX1R mRNA, but OX2R mRNA was expressed mainly in GABAergic putative interneurons. Thus, each orexin receptor subtype plays differential roles in gating NREM and REM sleep through distinct neuronal pathways.

Original languageEnglish (US)
Pages (from-to)6518-6526
Number of pages9
JournalJournal of Neuroscience
Volume31
Issue number17
DOIs
StatePublished - Apr 27 2011

Fingerprint

Orexin Receptors
REM Sleep
Eye Movements
Wakefulness
Sleep
Cholinergic Neurons
Pedunculopontine Tegmental Nucleus
Messenger RNA
Interneurons
Arousal
Neuropeptides
Knockout Mice
Brain Stem
Neurotransmitter Agents
Orexins
Maintenance

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differential roles of orexin receptor-1 and -2 in the regulation of Non-REM and REM sleep. / Mieda, Michihiro; Hasegawa, Emi; Kisanuki, Yaz Y.; Sinton, Christopher M.; Yanagisawa, Masashi; Sakurai, Takeshi.

In: Journal of Neuroscience, Vol. 31, No. 17, 27.04.2011, p. 6518-6526.

Research output: Contribution to journalArticle

Mieda, Michihiro ; Hasegawa, Emi ; Kisanuki, Yaz Y. ; Sinton, Christopher M. ; Yanagisawa, Masashi ; Sakurai, Takeshi. / Differential roles of orexin receptor-1 and -2 in the regulation of Non-REM and REM sleep. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 17. pp. 6518-6526.
@article{82e6c9d42b8d4dc28e042958409b90d2,
title = "Differential roles of orexin receptor-1 and -2 in the regulation of Non-REM and REM sleep",
abstract = "Orexin-A and orexin-B are hypothalamic neuropeptides that play critical roles in the maintenance of wakefulness. Intracerebroventricular (ICV) administration of orexin-A has been shown to promote wakefulness and suppress both rapid eye movement (REM) sleep and non-REM (NREM) sleep through the orexin receptor-1 (OX1R) and orexin receptor-2 (OX2R). Here, we elucidated the differential roles of orexin receptors in the regulation of sleep and wakefulness by comparing the effects of ICV orexin-A administration in wild-type, OX1R, and OX2R mice. The effects of orexin-A on wakefulness and NREM sleep were significantly attenuated in both knock-out mice as compared with wild-type mice, with substantially larger attenuation in OX2R mice than in OX1R mice. These results suggest that although the OX2R-mediated pathway has a pivotal role in the promotion of wakefulness, OX1R also plays additional roles in promoting arousal. In contrast, suppression of REM sleep by orexin-A administration was slightly and similarly attenuated in both OX1R and OX2R mice, suggesting a comparable contribution of the two receptors to REM sleep suppression. Histological studies demonstrated differential distributions of each receptor subtype in distinct neuronal populations with specific neurotransmitter identities in brainstem cholinergic/monoaminergic neurons. In the laterodorsal tegmental and pedunculopontine tegmental nuclei especially, cholinergic neurons exclusively expressed OX1R mRNA, but OX2R mRNA was expressed mainly in GABAergic putative interneurons. Thus, each orexin receptor subtype plays differential roles in gating NREM and REM sleep through distinct neuronal pathways.",
author = "Michihiro Mieda and Emi Hasegawa and Kisanuki, {Yaz Y.} and Sinton, {Christopher M.} and Masashi Yanagisawa and Takeshi Sakurai",
year = "2011",
month = "4",
day = "27",
doi = "10.1523/JNEUROSCI.6506-10.2011",
language = "English (US)",
volume = "31",
pages = "6518--6526",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "17",

}

TY - JOUR

T1 - Differential roles of orexin receptor-1 and -2 in the regulation of Non-REM and REM sleep

AU - Mieda, Michihiro

AU - Hasegawa, Emi

AU - Kisanuki, Yaz Y.

AU - Sinton, Christopher M.

AU - Yanagisawa, Masashi

AU - Sakurai, Takeshi

PY - 2011/4/27

Y1 - 2011/4/27

N2 - Orexin-A and orexin-B are hypothalamic neuropeptides that play critical roles in the maintenance of wakefulness. Intracerebroventricular (ICV) administration of orexin-A has been shown to promote wakefulness and suppress both rapid eye movement (REM) sleep and non-REM (NREM) sleep through the orexin receptor-1 (OX1R) and orexin receptor-2 (OX2R). Here, we elucidated the differential roles of orexin receptors in the regulation of sleep and wakefulness by comparing the effects of ICV orexin-A administration in wild-type, OX1R, and OX2R mice. The effects of orexin-A on wakefulness and NREM sleep were significantly attenuated in both knock-out mice as compared with wild-type mice, with substantially larger attenuation in OX2R mice than in OX1R mice. These results suggest that although the OX2R-mediated pathway has a pivotal role in the promotion of wakefulness, OX1R also plays additional roles in promoting arousal. In contrast, suppression of REM sleep by orexin-A administration was slightly and similarly attenuated in both OX1R and OX2R mice, suggesting a comparable contribution of the two receptors to REM sleep suppression. Histological studies demonstrated differential distributions of each receptor subtype in distinct neuronal populations with specific neurotransmitter identities in brainstem cholinergic/monoaminergic neurons. In the laterodorsal tegmental and pedunculopontine tegmental nuclei especially, cholinergic neurons exclusively expressed OX1R mRNA, but OX2R mRNA was expressed mainly in GABAergic putative interneurons. Thus, each orexin receptor subtype plays differential roles in gating NREM and REM sleep through distinct neuronal pathways.

AB - Orexin-A and orexin-B are hypothalamic neuropeptides that play critical roles in the maintenance of wakefulness. Intracerebroventricular (ICV) administration of orexin-A has been shown to promote wakefulness and suppress both rapid eye movement (REM) sleep and non-REM (NREM) sleep through the orexin receptor-1 (OX1R) and orexin receptor-2 (OX2R). Here, we elucidated the differential roles of orexin receptors in the regulation of sleep and wakefulness by comparing the effects of ICV orexin-A administration in wild-type, OX1R, and OX2R mice. The effects of orexin-A on wakefulness and NREM sleep were significantly attenuated in both knock-out mice as compared with wild-type mice, with substantially larger attenuation in OX2R mice than in OX1R mice. These results suggest that although the OX2R-mediated pathway has a pivotal role in the promotion of wakefulness, OX1R also plays additional roles in promoting arousal. In contrast, suppression of REM sleep by orexin-A administration was slightly and similarly attenuated in both OX1R and OX2R mice, suggesting a comparable contribution of the two receptors to REM sleep suppression. Histological studies demonstrated differential distributions of each receptor subtype in distinct neuronal populations with specific neurotransmitter identities in brainstem cholinergic/monoaminergic neurons. In the laterodorsal tegmental and pedunculopontine tegmental nuclei especially, cholinergic neurons exclusively expressed OX1R mRNA, but OX2R mRNA was expressed mainly in GABAergic putative interneurons. Thus, each orexin receptor subtype plays differential roles in gating NREM and REM sleep through distinct neuronal pathways.

UR - http://www.scopus.com/inward/record.url?scp=79955777621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955777621&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.6506-10.2011

DO - 10.1523/JNEUROSCI.6506-10.2011

M3 - Article

VL - 31

SP - 6518

EP - 6526

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 17

ER -